Last updated on October 2018

A Randomized Pivotal Study of RenewTM NCP-5 for the Treatment of Mild Cognitive Impairment due to Alzheimer’s Disease or Mild Dementia of the Alzheimer’s Type

Brief description of study

RenewTM NCP-5, an ECP device, is a non-invasive treatment that improves coronary and peripheral vascular health and may improve cerebral vascular health. It enhances circulation and stimulates endothelial production of trophic factors such as nitric oxide, resulting in peripheral vasodilation, reduction in vascular inflammation and improved vascular compliance. These and other factors result in increased coronary artery blood flow, reduced cardiac afterload and reduced systemic blood pressure.


Clinical Study Identifier: TX213549

Find a site near you

Start Over

Northwest Clinical Research Center

1951 152nd Pl NE Suite 200 Bellevue, WA United States
  Connect »